| Record ID | marc_columbia/Columbia-extract-20221130-013.mrc:136192523:3730 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-013.mrc:136192523:3730?format=raw |
LEADER: 03730cam a22004458a 4500
001 6163765
005 20221122002220.0
008 070108t20072007nyu bf 001 0 eng
010 $a 2007000620
016 7 $a101296841$2DNLM
020 $a9780849376214 (hb : alk. paper)
020 $a0849376211 (hb : alk. paper)
029 1 $aNLM$b101296841
029 1 $aYDXCP$b2480402
035 $a(OCoLC)ocm77830276
035 $a(OCoLC)77830276
035 $a(NNC)6163765
035 $a6163765
040 $aDNLM/DLC$cDLC$dBTCTA$dNLM$dYDXCP$dNNC-M$dOrLoB-B
042 $apcc
050 00 $aRC382$b.H36 2007
060 10 $aW1$bNE33LD v.92 2007
060 10 $aWL 359$bH236 2007
082 00 $a616.8/33$222
245 00 $aHandbook of Parkinson's disease /$c[edited by] Rajesh Pahwa, Kelly E. Lyons.
250 $a4th ed.
260 $aNew York :$bInforma Healthcare USA,$c[2007], ©2007.
300 $axi, 500 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aNeurological disease and therapy ;$v92
504 $aIncludes bibliographical references and index.
505 00 $g1.$tEarly iconography of Parkinson's disease /$rChristopher G. Goetz -- $g2.$tEpidemiology /$rMichele Rajput, Alex Rajput and Ali H. Rajput -- $g3.$tDifferential diagnosis /$rJohn Morgan and Kapil D. Sethi -- $g4.$tPathophysiology and clinical assessment /$rJoseph Jankovic -- $g5.$tAutonomic dysfunction and management /$rRichard B. Dewey, Jr. -- $g6.$tSleep dysfunction /$rLaura Nieder and K. Ray Chaudhuri -- $g7.$tNeuropsychological aspects /$rAlexander I. Troster and Steven Paul Woods -- $g8.$tManagement of anxiety and depression /$rJack J. Chen -- $g9.$tManagement of psychosis and dementia /$rKelvin L. Chou and Hubert H. Fernandez -- $g10.$tNeuroimaging /$rKenneth Marek, Danna Jennings and John Seibyl -- $g11.$tNeuropathology /$rDennis W. Dickson -- $g12.$tNeurochemistry of nigral degeneration /$rJayaraman Rao -- $g13.$tNeurophysiology and neurocircuitry /$rErwin B. Montgomery and John T. Gale -- $g14.$tAnimal models /$rGiselle M. Petzinger and Michael W. Jakowec -- $g15.$tGenetics /$rAkiko Imamura, Matthew J. Farrer and Zbigniew K. Wszolek -- $g16.$tEnvironmental risk factors /$rBrad A. Racette -- $g17.$tAmantadine and anticholinergics /$rKhashayar Dashtipour, Joseph S. Chung, Allan D. Wu and Mark F. Lew -- $g18.$tLevodopa /$rStewart A. Factor -- $g19.$tDopamine agonists /$rValerie Street and Mark Stacy -- $g20.$tMonoamine oxidase inhibitors /$rAlex Rajput, Theresa A. Zesiewicz and Robert A. Hauser -- $g21.$tCatechol-o-methyltransferase inhibitors /$rRonald F. Pfeiffer -- $g22.$tInvestigational pharmacological treatments /$rWilliam G. Ondo -- $g23.$tLesion surgeries /$rMichael Samuel, Keyoumars Ashkan and Anthony E. Lang -- $g24.$tDeep brain stimulation /$rKelly E. Lyons and Rajesh Pahwa -- $g25.$tInvestigational surgical therapies /$rJoseph S. Neimat, Parag G. Patil and Andres M. Lozano -- $g26.$tPhysical and occupational therapy /$rAtul T. Patel and Sean Shire -- $g27.$tVoice, speech, and swallowing disorders /$rShimon Sapir, Lorraine Olson Ramig and Cynthia Fox -- $g28.$tAlternative therapies /$rJill Marjama-Lyons.
650 0 $aParkinson's disease$vHandbooks, manuals, etc.
650 12 $aParkinson Disease.$0https://id.nlm.nih.gov/mesh/D010300
700 1 $aPahwa, Rajesh.$0http://id.loc.gov/authorities/names/n00119765
700 1 $aLyons, Kelly E.$0http://id.loc.gov/authorities/names/no2003043879
830 0 $aNeurological disease and therapy ;$vv. 92.$0http://id.loc.gov/authorities/names/n86728765
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip078/2007000620.html
852 00 $boff,hsl$hRC382$i.H36 2007